Published on in Vol 5, No 11 (2021): November
1 Orikami Digital Health Products, Nijmegen, The Netherlands
2 Dutch National Multiple Sclerosis Foundation, Rotterdam, The Netherlands
3 Radboud University Medical Center, Nijmegen, The Netherlands
4 Faculty of Science, Institute for Science in Society, Radboud University, Nijmegen, The Netherlands
5 Sint Maartenskliniek, Nijmegen, The Netherlands
6 Drug Target ID, Nijmegen, The Netherlands
7 NeuroDrug Research BV, Nijmegen, The Netherlands
8 Department of Community & Occupational Medicine, University Medical Centre Groningen, Groningen, The Netherlands
9 MS4 Research Institute, Nijmegen, The Netherlands